Back to search

Article

The Association and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Obstructive Sleep Apnoea: A Scoping Review

2026-08-07

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common cause of chronic liver disease, associated with the increasing prevalence of metabolic syndrome. Inflammatory and metabolic processes in MASLD may be linked to consequences of obstructive sleep apnoea (OSA), including intermittent hypoxia and fragmented sleep. However,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d41475bf-35a4-56be-b388-4c6befc10020
DOI
10.21203/rs.3.rs-10616114/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Association and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Obstructive Sleep Apnoea: A Scoping ReviewDOI 10.21203/rs.3.rs-10616114/v1
Select a neighboring publication to make it the new centre.